Czech Republic

Czech Republic

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.71 (0.61 - 0.79) 2019 Modelled IHME
0.71 (0.62 - 0.80) 2018 Modelled IHME
0.72 (0.62 - 0.82) 2017 Modelled IHME
0.73 (0.64 - 0.83) 2016 Modelled IHME
0.75 (0.65 - 0.85) 2015 Modelled IHME
0.76 (0.66 - 0.86) 2014 Modelled IHME
0.77 (0.67 - 0.87) 2013 Modelled IHME
0.79 (0.68 - 0.88) 2012 Modelled IHME
0.8 (0.68 - 0.89) 2011 Modelled IHME
0.81 (0.68 - 0.91) 2010 Modelled IHME
0.82 (0.70 - 0.92) 2009 Modelled IHME
0.84 (0.73 - 0.94) 2008 Modelled IHME
0.85 (0.75 - 0.96) 2007 Modelled IHME
0.87 (0.76 - 0.98) 2006 Modelled IHME
0.88 (0.77 - 1) 2005 Modelled IHME
0.88 (0.77 - 1) 2004 Modelled IHME
0.89 (0.78 - 1.01) 2003 Modelled IHME
0.89 (0.77 - 1.01) 2002 Modelled IHME
0.9 (0.78 - 1.02) 2001 Modelled IHME
0.9 (0.77 - 1.03) 2000 Modelled IHME
0.91 (0.78 - 1.04) 1999 Modelled IHME
0.92 (0.79 - 1.05) 1998 Modelled IHME
0.92 (0.80 - 1.05) 1997 Modelled IHME
0.93 (0.80 - 1.06) 1996 Modelled IHME
0.93 (0.81 - 1.07) 1995 Modelled IHME
0.94 (0.81 - 1.07) 1994 Modelled IHME
0.94 (0.82 - 1.08) 1993 Modelled IHME
0.95 (0.82 - 1.08) 1992 Modelled IHME
0.95 (0.82 - 1.08) 1991 Modelled IHME
0.95 (0.81 - 1.09) 1990 Modelled IHME
0.6 2001 Survey/reported Nardone A et al, 2009
0.3 (0.20 - 0.70) 2001 Survey/reported ECDC Monitoring Report 2019
1.33 (0.88 - 1.97) 2015 Modelled WHO
0.4 (0.20 - 0.50) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.03 (0.02 - 0.04) 2019 Modelled IHME
0.03 (0.02 - 0.04) 2018 Modelled IHME
0.03 (0.02 - 0.04) 2017 Modelled IHME
0.03 (0.02 - 0.04) 2016 Modelled IHME
0.03 (0.02 - 0.04) 2015 Modelled IHME
0.03 (0.02 - 0.04) 2014 Modelled IHME
0.03 (0.02 - 0.03) 2013 Modelled IHME
0.02 (0.02 - 0.03) 2012 Modelled IHME
0.02 (0.02 - 0.03) 2011 Modelled IHME
0.02 (0.02 - 0.03) 2010 Modelled IHME
0.02 (0.02 - 0.03) 2009 Modelled IHME
0.03 (0.02 - 0.03) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.02 - 0.04) 2006 Modelled IHME
0.03 (0.02 - 0.05) 2005 Modelled IHME
0.08 (0.06 - 0.10) 2004 Modelled IHME
0.18 (0.13 - 0.24) 2003 Modelled IHME
0.3 (0.22 - 0.40) 2002 Modelled IHME
0.41 (0.29 - 0.55) 2001 Modelled IHME
0.46 (0.32 - 0.62) 2000 Modelled IHME
0.47 (0.33 - 0.63) 1999 Modelled IHME
0.47 (0.34 - 0.63) 1998 Modelled IHME
0.48 (0.34 - 0.63) 1997 Modelled IHME
0.48 (0.34 - 0.64) 1996 Modelled IHME
0.48 (0.34 - 0.65) 1995 Modelled IHME
0.49 (0.34 - 0.65) 1994 Modelled IHME
0.49 (0.35 - 0.65) 1993 Modelled IHME
0.49 (0.34 - 0.66) 1992 Modelled IHME
0.49 (0.34 - 0.67) 1991 Modelled IHME
0.49 (0.34 - 0.68) 1990 Modelled IHME
0.39 (0.23 - 0.63) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
98,268 (83,607 - 112,066) 1990 Modelled IHME
97,865 (84,332 - 111,188) 1991 Modelled IHME
97,440 (84,404 - 110,779) 1992 Modelled IHME
96,992 (84,077 - 110,708) 1993 Modelled IHME
96,476 (83,730 - 110,473) 1994 Modelled IHME
95,874 (83,161 - 109,992) 1995 Modelled IHME
95,209 (82,583 - 109,074) 1996 Modelled IHME
94,502 (81,593 - 108,151) 1997 Modelled IHME
93,798 (80,892 - 107,133) 1998 Modelled IHME
93,141 (80,048 - 106,322) 1999 Modelled IHME
92,564 (79,095 - 105,969) 2000 Modelled IHME
92,097 (79,470 - 104,220) 2001 Modelled IHME
91,700 (79,346 - 103,994) 2002 Modelled IHME
91,310 (79,615 - 103,394) 2003 Modelled IHME
90,894 (79,182 - 102,868) 2004 Modelled IHME
90,411 (78,850 - 102,996) 2005 Modelled IHME
89,625 (78,611 - 100,903) 2006 Modelled IHME
88,483 (77,265 - 99,239) 2007 Modelled IHME
87,148 (75,584 - 97,599) 2008 Modelled IHME
85,788 (73,145 - 96,219) 2009 Modelled IHME
84,585 (71,557 - 95,474) 2010 Modelled IHME
83,564 (71,653 - 93,802) 2011 Modelled IHME
82,594 (71,858 - 92,473) 2012 Modelled IHME
81,628 (70,928 - 91,547) 2013 Modelled IHME
80,613 (70,150 - 90,698) 2014 Modelled IHME
79,472 (69,140 - 90,041) 2015 Modelled IHME
77,884 (67,623 - 87,749) 2016 Modelled IHME
76,473 (65,410 - 87,471) 2017 Modelled IHME
75,645 (65,555 - 84,600) 2018 Modelled IHME
75,045 (65,349 - 83,843) 2019 Modelled IHME
45,000 (19,000 - 58,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.75 (3.45 - 6.39) 2019 Modelled IHME
4.77 (3.47 - 6.34) 2018 Modelled IHME
4.75 (3.57 - 6.13) 2017 Modelled IHME
4.71 (3.51 - 6.10) 2016 Modelled IHME
4.76 (3.56 - 6.16) 2015 Modelled IHME
5.07 (3.80 - 6.54) 2014 Modelled IHME
5.93 (4.48 - 7.53) 2013 Modelled IHME
6.84 (5.22 - 8.59) 2012 Modelled IHME
7.63 (5.90 - 9.49) 2011 Modelled IHME
7.97 (6.21 - 9.90) 2010 Modelled IHME
8.07 (6.26 - 9.96) 2009 Modelled IHME
8.2 (6.38 - 10.10) 2008 Modelled IHME
8.11 (6.32 - 9.99) 2007 Modelled IHME
8 (6.24 - 9.81) 2006 Modelled IHME
8.13 (6.37 - 9.99) 2005 Modelled IHME
7.99 (6.32 - 9.80) 2004 Modelled IHME
8.06 (6.42 - 9.85) 2003 Modelled IHME
7.62 (6.16 - 9.22) 2002 Modelled IHME
7.53 (6.11 - 9.05) 2001 Modelled IHME
7.29 (5.95 - 8.77) 2000 Modelled IHME
7.12 (5.84 - 8.50) 1999 Modelled IHME
7.04 (5.82 - 8.38) 1998 Modelled IHME
7.12 (5.86 - 8.43) 1997 Modelled IHME
6.94 (5.76 - 8.23) 1996 Modelled IHME
7.01 (5.81 - 8.31) 1995 Modelled IHME
6.88 (5.69 - 8.15) 1994 Modelled IHME
6.88 (5.72 - 8.14) 1993 Modelled IHME
7.23 (6 - 8.54) 1992 Modelled IHME
7.39 (6.17 - 8.83) 1991 Modelled IHME
7.7 (6.45 - 9.19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
506 (367 - 680) 2019 Modelled IHME
507 (369 - 674) 2018 Modelled IHME
504 (379 - 651) 2017 Modelled IHME
499 (372 - 647) 2016 Modelled IHME
503 (376 - 652) 2015 Modelled IHME
535 (401 - 690) 2014 Modelled IHME
625 (473 - 794) 2013 Modelled IHME
720 (549 - 903) 2012 Modelled IHME
801 (619 - 997) 2011 Modelled IHME
835 (650 - 1,037) 2010 Modelled IHME
842 (653 - 1,040) 2009 Modelled IHME
853 (663 - 1,053) 2008 Modelled IHME
840 (654 - 1,035) 2007 Modelled IHME
825 (644 - 1,013) 2006 Modelled IHME
836 (655 - 1,028) 2005 Modelled IHME
821 (649 - 1,006) 2004 Modelled IHME
827 (658 - 1,010) 2003 Modelled IHME
781 (632 - 945) 2002 Modelled IHME
771 (626 - 927) 2001 Modelled IHME
747 (609 - 899) 2000 Modelled IHME
730 (598 - 871) 1999 Modelled IHME
721 (596 - 858) 1998 Modelled IHME
730 (600 - 865) 1997 Modelled IHME
712 (591 - 845) 1996 Modelled IHME
720 (597 - 854) 1995 Modelled IHME
708 (586 - 838) 1994 Modelled IHME
709 (589 - 838) 1993 Modelled IHME
744 (618 - 880) 1992 Modelled IHME
761 (635 - 909) 1991 Modelled IHME
793 (664 - 947) 1990 Modelled IHME
675 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
17 (12 - 24) 2019 Modelled IHME
17 (12 - 24) 2018 Modelled IHME
17 (12 - 24) 2017 Modelled IHME
17 (12 - 24) 2016 Modelled IHME
17 (12 - 25) 2015 Modelled IHME
18 (12 - 25) 2014 Modelled IHME
19 (13 - 26) 2013 Modelled IHME
19 (14 - 27) 2012 Modelled IHME
20 (14 - 28) 2011 Modelled IHME
20 (14 - 28) 2010 Modelled IHME
21 (14 - 28) 2009 Modelled IHME
21 (15 - 28) 2008 Modelled IHME
21 (15 - 28) 2007 Modelled IHME
21 (15 - 28) 2006 Modelled IHME
21 (15 - 28) 2005 Modelled IHME
21 (15 - 28) 2004 Modelled IHME
21 (15 - 28) 2003 Modelled IHME
21 (15 - 28) 2002 Modelled IHME
21 (15 - 29) 2001 Modelled IHME
21 (15 - 29) 2000 Modelled IHME
21 (15 - 29) 1999 Modelled IHME
21 (15 - 29) 1998 Modelled IHME
21 (15 - 29) 1997 Modelled IHME
21 (15 - 29) 1996 Modelled IHME
21 (15 - 29) 1995 Modelled IHME
21 (15 - 29) 1994 Modelled IHME
21 (15 - 29) 1993 Modelled IHME
21 (15 - 29) 1992 Modelled IHME
21 (15 - 29) 1991 Modelled IHME
21 (15 - 29) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
92 2003 Survey/reported WHO/UNICEF
86 2002 Survey/reported WHO/UNICEF
97 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
147 2017 Survey/reported EMCDDA, 2017
137 (131 - 144) 2016 Survey/reported EMCDDA, 2016
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
38 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.82 (0.66 - 0.99) 2019 Modelled IHME
0.81 (0.66 - 0.98) 2018 Modelled IHME
0.81 (0.65 - 0.98) 2017 Modelled IHME
0.81 (0.66 - 0.97) 2016 Modelled IHME
0.8 (0.66 - 0.97) 2015 Modelled IHME
0.8 (0.66 - 0.97) 2014 Modelled IHME
0.81 (0.67 - 0.98) 2013 Modelled IHME
0.82 (0.67 - 1) 2012 Modelled IHME
0.82 (0.67 - 1.01) 2011 Modelled IHME
0.82 (0.67 - 1.01) 2010 Modelled IHME
0.81 (0.67 - 1) 2009 Modelled IHME
0.79 (0.65 - 0.96) 2008 Modelled IHME
0.77 (0.62 - 0.93) 2007 Modelled IHME
0.74 (0.60 - 0.90) 2006 Modelled IHME
0.73 (0.59 - 0.90) 2005 Modelled IHME
0.73 (0.59 - 0.89) 2004 Modelled IHME
0.73 (0.59 - 0.89) 2003 Modelled IHME
0.73 (0.59 - 0.89) 2002 Modelled IHME
0.73 (0.59 - 0.88) 2001 Modelled IHME
0.72 (0.59 - 0.89) 2000 Modelled IHME
0.73 (0.60 - 0.89) 1999 Modelled IHME
0.74 (0.61 - 0.91) 1998 Modelled IHME
0.76 (0.62 - 0.92) 1997 Modelled IHME
0.78 (0.63 - 0.95) 1996 Modelled IHME
0.78 (0.64 - 0.96) 1995 Modelled IHME
0.79 (0.64 - 0.97) 1994 Modelled IHME
0.79 (0.64 - 0.97) 1993 Modelled IHME
0.8 (0.64 - 0.98) 1992 Modelled IHME
0.8 (0.65 - 0.98) 1991 Modelled IHME
0.8 (0.64 - 0.98) 1990 Modelled IHME
0.4 (0.20 - 0.50) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.7 (1.20 - 2.20) 2015 Survey/reported Chlibeck, 2017
0.7 (0.20 - 0.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
18.3 (14.50 - 22.20) 2015 Modelled Degenhardt L et al, 2017
14.6 (13.10 - 16.30) 2013 Survey/reported EMCDDA
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
82,186 (66,148 - 100,818) 1990 Modelled IHME
82,105 (66,591 - 100,864) 1991 Modelled IHME
81,901 (66,314 - 100,632) 1992 Modelled IHME
81,592 (66,057 - 99,659) 1993 Modelled IHME
81,160 (65,633 - 99,501) 1994 Modelled IHME
80,610 (65,331 - 98,960) 1995 Modelled IHME
79,566 (64,738 - 97,070) 1996 Modelled IHME
77,932 (63,642 - 94,312) 1997 Modelled IHME
76,184 (61,998 - 92,932) 1998 Modelled IHME
74,794 (61,218 - 91,374) 1999 Modelled IHME
74,227 (60,211 - 90,999) 2000 Modelled IHME
74,269 (60,292 - 90,597) 2001 Modelled IHME
74,390 (60,427 - 90,782) 2002 Modelled IHME
74,579 (60,686 - 91,168) 2003 Modelled IHME
74,853 (60,821 - 91,265) 2004 Modelled IHME
75,222 (61,016 - 92,169) 2005 Modelled IHME
76,581 (62,075 - 93,389) 2006 Modelled IHME
79,271 (64,473 - 96,391) 2007 Modelled IHME
82,396 (67,655 - 100,150) 2008 Modelled IHME
85,046 (69,834 - 104,113) 2009 Modelled IHME
86,301 (70,235 - 105,499) 2010 Modelled IHME
86,275 (70,831 - 105,578) 2011 Modelled IHME
85,867 (70,604 - 104,728) 2012 Modelled IHME
85,326 (70,137 - 103,781) 2013 Modelled IHME
84,899 (69,881 - 102,947) 2014 Modelled IHME
84,812 (69,390 - 102,789) 2015 Modelled IHME
85,338 (70,068 - 102,454) 2016 Modelled IHME
86,017 (69,169 - 103,969) 2017 Modelled IHME
86,467 (70,115 - 104,419) 2018 Modelled IHME
86,854 (70,776 - 105,277) 2019 Modelled IHME
43,000 (22,000 - 49,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.4 (3.90 - 7.35) 2019 Modelled IHME
5.42 (4.01 - 7.23) 2018 Modelled IHME
5.38 (4.11 - 6.94) 2017 Modelled IHME
5.32 (4.11 - 6.84) 2016 Modelled IHME
5.32 (4.12 - 6.91) 2015 Modelled IHME
5.2 (4.01 - 6.78) 2014 Modelled IHME
5.14 (3.96 - 6.71) 2013 Modelled IHME
5.01 (3.81 - 6.48) 2012 Modelled IHME
4.94 (3.78 - 6.39) 2011 Modelled IHME
4.96 (3.78 - 6.37) 2010 Modelled IHME
5.02 (3.86 - 6.40) 2009 Modelled IHME
5.12 (3.95 - 6.57) 2008 Modelled IHME
5.1 (3.93 - 6.59) 2007 Modelled IHME
5.04 (3.88 - 6.49) 2006 Modelled IHME
5.1 (3.91 - 6.60) 2005 Modelled IHME
5.02 (3.89 - 6.49) 2004 Modelled IHME
5.08 (3.96 - 6.53) 2003 Modelled IHME
4.85 (3.80 - 6.18) 2002 Modelled IHME
4.78 (3.74 - 6.13) 2001 Modelled IHME
4.68 (3.64 - 5.95) 2000 Modelled IHME
4.59 (3.61 - 5.82) 1999 Modelled IHME
4.55 (3.57 - 5.72) 1998 Modelled IHME
4.61 (3.68 - 5.79) 1997 Modelled IHME
4.5 (3.59 - 5.64) 1996 Modelled IHME
4.55 (3.64 - 5.69) 1995 Modelled IHME
4.46 (3.56 - 5.60) 1994 Modelled IHME
4.49 (3.59 - 5.64) 1993 Modelled IHME
4.69 (3.72 - 5.89) 1992 Modelled IHME
4.8 (3.79 - 6.01) 1991 Modelled IHME
4.98 (3.95 - 6.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
575 (415 - 782) 2019 Modelled IHME
576 (426 - 769) 2018 Modelled IHME
571 (437 - 736) 2017 Modelled IHME
564 (435 - 725) 2016 Modelled IHME
563 (436 - 732) 2015 Modelled IHME
549 (423 - 716) 2014 Modelled IHME
542 (417 - 707) 2013 Modelled IHME
527 (401 - 682) 2012 Modelled IHME
519 (396 - 671) 2011 Modelled IHME
519 (396 - 667) 2010 Modelled IHME
524 (403 - 668) 2009 Modelled IHME
532 (411 - 683) 2008 Modelled IHME
528 (407 - 682) 2007 Modelled IHME
520 (400 - 670) 2006 Modelled IHME
525 (403 - 679) 2005 Modelled IHME
516 (399 - 666) 2004 Modelled IHME
522 (407 - 670) 2003 Modelled IHME
497 (390 - 634) 2002 Modelled IHME
490 (383 - 628) 2001 Modelled IHME
479 (373 - 609) 2000 Modelled IHME
470 (370 - 596) 1999 Modelled IHME
466 (366 - 586) 1998 Modelled IHME
473 (377 - 594) 1997 Modelled IHME
462 (369 - 579) 1996 Modelled IHME
468 (374 - 585) 1995 Modelled IHME
459 (366 - 577) 1994 Modelled IHME
462 (369 - 581) 1993 Modelled IHME
483 (383 - 606) 1992 Modelled IHME
494 (391 - 619) 1991 Modelled IHME
513 (407 - 651) 1990 Modelled IHME
530 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
24 (17 - 32) 2018 Modelled IHME
24 (17 - 32) 2017 Modelled IHME
24 (17 - 32) 2016 Modelled IHME
24 (17 - 32) 2015 Modelled IHME
24 (17 - 32) 2014 Modelled IHME
24 (17 - 32) 2013 Modelled IHME
24 (16 - 32) 2012 Modelled IHME
24 (16 - 32) 2011 Modelled IHME
24 (16 - 31) 2010 Modelled IHME
24 (16 - 31) 2009 Modelled IHME
24 (16 - 31) 2008 Modelled IHME
24 (16 - 31) 2007 Modelled IHME
23 (16 - 31) 2006 Modelled IHME
23 (16 - 31) 2005 Modelled IHME
23 (16 - 31) 2004 Modelled IHME
23 (16 - 31) 2003 Modelled IHME
23 (16 - 31) 2002 Modelled IHME
23 (16 - 31) 2001 Modelled IHME
23 (16 - 30) 2000 Modelled IHME
23 (16 - 30) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (16 - 30) 1997 Modelled IHME
23 (16 - 30) 1996 Modelled IHME
23 (16 - 31) 1995 Modelled IHME
23 (16 - 31) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
23 (16 - 31) 1992 Modelled IHME
23 (16 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
147 2017 Survey/reported EMCDDA, 2017
137 (131 - 144) 2016 Survey/reported EMCDDA, 2016
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
38 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
506
2019
(367 - 680)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
575
2019
(415 - 782)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
147
2017
EMCDDA, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines